Indication
Treatment to slow progression of coronary artery disease
Coronary artery disease is a chronic cardiovascular disorder characterized by the gradual accumulation of fibrofatty atherosclerotic plaques within the epicardial coronary arteries. Read more about Treatment to slow progression of coronary artery disease
189 drugs 105 manufacturers
Drugs that treat it
Common Treatment to slow progression of coronary artery disease therapies.
ATORVASTATIN CALCIUM
LOVASTATIN
PRAVASTATIN SODIUM
SIMVASTATIN
AMLODIPINE-ATORVASTATIN (amlodipine besylate/atorvastatin calcium)
ATORVASTATIN CALCIUM
FLUVASTATIN SODIUM
LOVASTATIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCoronary artery disease is a chronic cardiovascular disorder characterized by the gradual accumulation of fibrofatty atherosclerotic plaques within the epicardial coronary arteries.
This process involves lipid retention, chronic vascular inflammation, endothelial dysfunction, and smooth muscle cell proliferation, which progressively narrow the arterial lumen and restrict myocardial perfusion.
Clinically, continuing plaque advancement increases the likelihood of luminal stenosis and plaque instability, which may manifest as chronic stable angina, acute coronary syndromes, ischemic cardiomyopathy, or fatal ischemic events.
Treatment to slow progression of coronary artery disease targets this underlying vascular pathology in affected individuals to inhibit further atheroma growth, stabilize vulnerable plaque architecture, and mitigate long-term adverse ischemic complications.
- controlledreleasesociety.org
Coronary artery disease is a chronic cardiovascular disorder characterized by the gradual accumulation of fibrofatty atherosclerotic plaques within the epicardial coronary arteries This process involves lipid retention, chronic vascular inflammation, endothelial dysfunction, and smooth muscle cell proliferation, which progressively narrow the arterial lumen and restrict myocardial perfusion Treatment to slow progression of coronary artery disease targets this underlying vascular pathology in aff...
- dokumen.pub
Coronary artery disease is a chronic cardiovascular disorder characterized by the gradual accumulation of fibrofatty atherosclerotic plaques within the epicardial coronary arteries Clinically, continuing plaque advancement increases the likelihood of luminal stenosis and plaque instability, which may manifest as chronic stable angina, acute coronary syndromes, ischemic cardiomyopathy, or fatal ischemic events
- uconn.edu
Clinically, continuing plaque advancement increases the likelihood of luminal stenosis and plaque instability, which may manifest as chronic stable angina, acute coronary syndromes, ischemic cardiomyopathy, or fatal ischemic events Treatment to slow progression of coronary artery disease targets this underlying vascular pathology in affected individuals to inhibit further atheroma growth, stabilize vulnerable plaque architecture, and mitigate long-term adverse ischemic complications
Personalize your experience
Follow Treatment to slow progression of coronary artery disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.